Gemmer Asset Management LLC Dexcom Inc Transaction History

Gemmer Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$67.99 - $132.89 $135 - $265	-2 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$80.99 - $107.93 $161 - $215	2 New	2 $1,000
Q1 2021 Apr 20, 2021	SELL	$84.79 - $104.74 $1,865 - $2,304	-22 Closed	0 $0
Q4 2020 Jan 28, 2021	SELL	$78.0 - $104.5 $624 - $836	-8 Reduced 26.67%	22 $8,000
Q2 2020 Jul 31, 2020	BUY	$62.68 - $105.34 $1,880 - $3,160	30 New	30 $12,000

Q1 2018 May 11, 2018	SELL	$13.06 - $18.54 $130 - $185	-10 Closed	0 $0
Q3 2017 Oct 12, 2017	BUY	$11.36 - $18.98 $113 - $189	10	10 $0

1,124

353M

4.19M

4.54M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $42.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.